Dabomb Protein (6578) — Capital Reinvestment Ratio
Dabomb Protein (6578) has a Capital Reinvestment Ratio of 2.53x as of March 2025, meaning it reinvests 3% of its operating cash flow (NT$8.12 Million) in capital expenditures (NT$20.59 Million). See 6578 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dabomb Protein Capital Reinvestment Ratio (2015–2025)
This chart tracks Dabomb Protein's Capital Reinvestment Ratio across 10 annual periods. Check cash flow reinvestment rate of Dabomb Protein to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dabomb Protein (2015–2025)
Year-by-year Capital Reinvestment Ratio for Dabomb Protein from 2015 to 2025. For live market cap and broader valuation context, see Dabomb Protein (6578) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.26x | NT$16.65 Million | NT$37.69 Million | ▲ +255.1% |
| 2024 | 0.64x | NT$47.55 Million | NT$30.32 Million | ▼ -78.0% |
| 2023 | 2.90x | NT$6.51 Million | NT$18.87 Million | ▲ +183.6% |
| 2022 | 1.02x | NT$19.71 Million | NT$20.16 Million | ▼ -25.1% |
| 2020 | 1.37x | NT$13.41 Million | NT$18.31 Million | ▼ -50.5% |
| 2019 | 2.76x | NT$33.26 Million | NT$91.81 Million | ▼ -62.6% |
| 2018 | 7.39x | NT$22.07 Million | NT$163.06 Million | ▲ +94.7% |
| 2017 | 3.79x | NT$43.87 Million | NT$166.46 Million | ▲ +143.9% |
| 2016 | 1.56x | NT$59.58 Million | NT$92.71 Million | ▲ +3977.6% |
| 2015 | 0.04x | NT$139.78 Million | NT$5.33 Million | — |